Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new ...

Hims & Hers Health launched a compounded semaglutide based weight loss pill, then quickly pulled it following legal threats from Novo Nordisk and federal scrutiny. Federal regulators have referred the ...

Boxes of the diabetes drug Ozempic rest on a pharmacy counter in Los Angeles. Drugs like Ozempic have grown in popularity to treat obesity, prompting more than a dozen states to pay for them. But with ...

Yesterday Health.com examined “fat camps for grown-ups” — aka weight loss spas and retreats. The conclusion: as with any diet, results are spotty. Health.com’s Sarah Klein talked to Jill Ackerman, who ...

In today’s Pharma Pulse, a telehealth giant retreats from the weight loss pill conflict, while safety-net hospitals secure a major legal victory against 340B reform.